| 2026-05-12 |
详情>>
内部人交易：
Bozic Carmen股份减少6988.00股
|
| 2026-05-05 |
详情>>
股本变动：
变动后总股本25380.54万股
|
| 2026-05-05 |
详情>>
业绩披露：
2026年一季报每股收益4.06美元,归母净利润10.31亿美元,同比去年增长59.59%
|
| 2026-05-04 |
财报披露：
美东时间 2026-05-04 盘后发布财报
|
| 2026-04-02 |
股东大会：
将于2026-05-13召开股东大会
会议内容 ▼▲
- 1.To elect the eleven director nominees that are set forth in the attached proxy statement to our board of directors to serve for a one year term until the 2027 annual meeting of shareholders and until such person’s successor has been duly elected and qualified;
2.To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for 2026;
3.To hold an advisory vote on our 2025 named executive officer compensation;
4.To approve our 2026 Stock and Option Plan;
5.On one proposal submitted by a shareholder, if properly presented at the meeting.
|
| 2026-02-13 |
详情>>
业绩披露：
2023年年报每股收益14.05美元,归母净利润36.20亿美元,同比去年增长8.96%
|
| 2026-02-13 |
详情>>
业绩披露：
2025年年报每股收益15.46美元,归母净利润39.53亿美元,同比去年增长838.09%
|
| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益10.77美元,归母净利润27.62亿美元,同比去年增长290.67%
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益6.54美元,归母净利润16.79亿美元,同比去年增长167.33%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益2.52美元,归母净利润6.46亿美元,同比去年增长-41.22%
|
| 2025-04-03 |
股东大会：
将于2025-05-14召开股东大会
会议内容 ▼▲
- 1.To elect the eleven director nominees that are set forth in the attached proxy statement to our board of directors to serve for a one-year term until the 2026 annual meeting of shareholders and until such person’s successor has been duly elected and qualified;
2.To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for 2025;
3.To hold an advisory vote on our 2024 named executive officer compensation;
4.On one proposal submitted by a shareholder, if properly presented at the meeting.
|
| 2025-02-13 |
详情>>
业绩披露：
2024年年报每股收益-2.08美元,归母净利润-5.36亿美元,同比去年增长-114.8%
|
| 2025-02-13 |
详情>>
业绩披露：
2022年年报每股收益12.97美元,归母净利润33.22亿美元,同比去年增长41.84%
|
| 2024-11-05 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-5.61美元,归母净利润-14.49亿美元,同比去年增长-154.65%
|
| 2024-08-02 |
详情>>
业绩披露：
2024年中报每股收益-9.66美元,归母净利润-24.94亿美元,同比去年增长-254.38%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益4.26美元,归母净利润11.00亿美元,同比去年增长57.13%
|
| 2024-04-04 |
股东大会：
将于2024-05-15召开股东大会
会议内容 ▼▲
- 1.To elect the eleven director nominees that are set forth in the attached proxy statement to our board of directors to serve for a one-year term until the 2025 annual meeting of shareholders and until such person’s successor has been duly elected and qualified;
2.To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for 2024;
3.To hold an advisory vote on our 2023 named executive officer compensation;
4.On two proposals submitted by our shareholders, if properly presented at the meeting.
|
| 2023-04-06 |
股东大会：
将于2023-05-17召开股东大会
会议内容 ▼▲
- 1.To elect the nine director nominees that are set forth in the attached proxy statement to our board of directors to serve for a one-year term until the 2024 annual meeting of shareholders and until such person’s successor has been duly elected and qualified;
2.To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for 2023;
3.To hold an advisory vote on our 2022 named executive officer compensation;
4.To hold an advisory vote on the frequency of future advisory votes on our executive compensation.
|
| 2023-04-06 |
股东大会：
将于2023-05-17召开股东大会
会议内容 ▼▲
- 1.To elect the nine director nominees that are set forth in the attached proxy statement to our board of directors to serve for a one-year term until the 2024 annual meeting of shareholders and until such person’s successor has been duly elected and qualified;
2.To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for 2023;
3.To hold an advisory vote on our 2022 named executive officer compensation;
4.To hold an advisory vote on the frequency of future advisory votes on our executive compensation.
|
| 2022-04-07 |
股东大会：
将于2022-05-18召开股东大会
会议内容 ▼▲
- 1.to elect the 11 director nominees that are set forth in the attached proxy statement to our board of directors to serve for a one-year term until the 2023 annual meeting of shareholders and until his or her successor has been duly elected and qualified;
2.to ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for 2022;
3.to approve our 2021 named executive officer compensation in an advisory vote;
4.to approve an amendment and restatement of our 2013 Stock and Option Plan to increase the number of shares authorized for issuance under this plan by 13.5 million shares.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-08 |
股东大会：
将于2021-05-19召开股东大会
会议内容 ▼▲
- 1.To elect the ten director nominees that are set forth in the attached proxy statement to our board of directors to serve for a one-year term until the 2022 annual meeting of shareholders and until his or her successor has been duly elected and qualified;
2.to ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for 2021;
3.to approve our 2020 named executive officer compensation in an advisory vote;
4.on two proposals submitted by our shareholders, if properly presented at the meeting.
|
| 2020-04-28 |
股东大会：
将于2020-06-03召开股东大会
会议内容 ▼▲
- 1.to elect the ten director nominees that are set forth in the attached proxy statement to our board of directors to serve for a one-year term until the 2021 annual meeting of shareholders and until his or her successor has been duly elected and qualified;
2.to ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for 2020;
3.to approve our 2019 named executive officer compensation in an advisory vote;
4.on one proposal submitted by a shareholder, if properly presented at the meeting.
|
| 2019-10-22 |
复牌提示：
2019-10-21 14:59:25 停牌，复牌日期 2019-10-21 16:20:00
|
| 2019-04-26 |
股东大会：
将于2019-06-05召开股东大会
会议内容 ▼▲
- 1.to elect the six director nominees that are set forth in the attached proxy statement to one year terms expiring in 2020;
2.to approve an amendment and restatement of our 2013 Stock and Option Plan, that, among other things, increases the number of shares authorized for issuance under this plan by 5.0 million shares;
3.to approve an amendment and restatement of our Employee Stock Purchase Plan that, among other things, increases the number of shares authorized for issuance under this plan by 2.0 million shares;
4.to ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for 2019;
5.to approve our named executive officers’ compensation in an advisory vote;
6.on two proposals submitted by our shareholders, if properly presented at the meeting.
|
| 2018-04-17 |
股东大会：
将于2018-05-17召开股东大会
会议内容 ▼▲
- 1.to elect the three director nominees that are set forth in the attached proxy statement to one year terms expiring in 2019;
2.to approve amendments to our Restated Articles of Organization and Amended and Restated By-laws that eliminate supermajority provisions;
3.to approve an amendment and restatement of our 2013 Stock and Option Plan, that, among other things, increases the number of shares authorized for issuance under this plan by 8.0 million shares;
4.to ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for 2018;
5.to approve our named executive officers’ compensation in an advisory vote; 6.on two proposals submitted by our shareholders, if properly presented at the meeting.
|
| 2017-04-28 |
股东大会：
将于2017-06-08召开股东大会
会议内容 ▼▲
- 1.to elect the three director nominees that are set forth in the attached proxy statement to the class of directors whose term will expire in 2020;
2.to approve amendments to our Restated Articles of Organization and By-laws that provide for the declassification of our board of directors;
3.to approve an amendment and restatement of our 2013 Stock and Option Plan, that, among other things, increases the number of shares authorized for issuance under this plan by 6.75 million shares;
4.to ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for 2017;
5.to approve our named executive officers’ compensation in an advisory vot;
6.to recommend, by a non-binding advisory vote, the frequency with which we should request advisory votes on our executive compensation program in the future;
7.on two proposals submitted by our shareholders, if properly presented at the meeting.
|
| 2016-04-29 |
股东大会：
将于2016-06-15召开股东大会
会议内容 ▼▲
- 1.to elect the four director nominees that are set forth in the attached proxy statement to the class of directors whose term will expire in 2019;
2.to ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for 2016;
3.to approve our named executive officers’ compensation in an advisory vote;
4.on four proposals submitted by our shareholders, if properly presented at the meeting.
|